On this episode of Managed Care Cast, Kristine Ashcraft, president and founder of YouScript, explains the importance of biomarker testing to distribute proper treatments to patients and minimize adverse events.
On this episode of Managed Care Cast, we're talking with Kristine Ashcraft, the president and founder of YouScript, a tool that helps to predict adverse drug events and personalize patient care.
We discuss the lack of awareness of genetic variants among patients and the recent adoption of biomarker testing legislation in some states. This legislation will increase biomarker testing access, which will help providers to distribute the proper treatments to more patients based on identified genetic variants.
Listen above or on one of these podcast services:
Despite Record ACA Enrollment, Report Reveals Underinsured Americans are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access and affordability to health care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Surgeon General Calls for Action on Tobacco Use, Outcomes Disparities
November 19th 2024The new report from US Surgeon General Vivek H. Murthy, MD, MBA, highlights persistent disparities in tobacco use and secondhand smoke exposure, calling for equitable strategies to achieve a tobacco-free future.
Read More